Craft
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
banner
Abbott key operating metrics including Manufacturing Sites (Cardiovascular and Neuromodulation Products), environmental, and social and governance score (ESG).

Manufacturing Sites (Cardiovascular and Neuromodulation Products)

31
10.7%

FY, 2023

Manufacturing Sites (Nutritional Products)

14

FY, 2023

Manufacturing Sites (Established Pharmaceutical Products)

24

FY, 2023

Operating Metrics

MetricsFY, 2021FY, 2022FY, 2023
Manufacturing Sites (Cardiovascular and Neuromodulation Products)272831
Manufacturing Sites (Nutritional Products)141414
Manufacturing Sites (Established Pharmaceutical Products)252424
Manufacturing Sites (Diagnostic Products)242221
Facility Space, sq. ft.43M43M44M
Remaining Performance Obligations (Medical Devices)$435.0M$432.0M$478.0M
Remaining Performance Obligations (Diagnostic Products)$4.0B$4.0B$4.4B
Reportable Segments444

Environmental, Social and Governance (ESG)

Overall

60-79 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal
Learn more

Source:CSRHub

Footer menu